Grapefruit — Benefits Deep Dive

Grapefruit is a fruit with an unusually split reputation: a wholesome, low-calorie, vitamin-C-rich breakfast staple on one hand, and the only common food with a warning printed on prescription labels on the other. Both are true at once, and understanding why is more useful than picking a side. The four deep-dive pages below cover the drug interaction in the detail it deserves — the enzyme it disables, exactly which drug classes are affected, how long the effect lasts, and, importantly, which medicines are not affected; the naringin and naringenin flavonoids that give grapefruit its bitterness and account for most of its metabolic research, read honestly against what has actually been shown in people rather than mice; the vitamin C that makes half a grapefruit cover roughly half a day's requirement, and what that vitamin genuinely does inside an immune cell; and the lycopene, pectin and potassium in red varieties that carry most of grapefruit's cardiovascular story. Where the evidence is strong, these pages say so. Where it is thin — the weight-loss literature especially — they say that instead.

Deep-Dive Articles

Grapefruit and Drug Interactions

The single most important fact about grapefruit, explained properly. Furanocoumarins — bergamottin and 6',7'-dihydroxybergamottin — irreversibly destroy the CYP3A4 enzyme in your intestinal wall, so far more of certain drugs reaches the blood than the dose intended. Why spacing your pill away from breakfast does not work; why one glass is enough; which classes are affected (simvastatin and lovastatin, some calcium-channel blockers, transplant immunosuppressants, certain antiarrhythmics and sedatives); which are not; and the reassuring half nobody prints — if you take none of them, grapefruit is just a fruit.

Naringin and Naringenin

The bitter flavanones that define grapefruit's taste and carry most of its metabolic research. Why naringin has to be converted by your gut bacteria before it does anything, why that keeps blood levels far below what laboratory studies use, what the mouse work on blood lipids and blood sugar really shows, and where the human evidence actually stands — including the six-month arterial-stiffness trial that is grapefruit's best result, and the weight-loss trials that found grapefruit no better than plain water.

Vitamin C and Immune Function

Half a grapefruit covers roughly half an adult's daily vitamin C. What that vitamin does inside a neutrophil — which concentrates it to many times the level in your blood and spends it during infection — plus the collagen and barrier work that is at least as important. The Cochrane evidence on colds, stated honestly: no fewer colds for most people, modestly shorter ones, and a large effect only under extreme physical stress. Why absorption saturates, and how to keep the vitamin C in the fruit.

Lycopene and Heart Health

Why red beats white, and what else in the fruit matters. Lycopene in Star Ruby and Rio Red, and how much fat you need in the meal to absorb it; the trial that compared red against blond grapefruit in heart patients and found lower triglycerides; the pectin study that lowered cholesterol with nothing else changed — the part juicing throws away; potassium and arterial stiffness; and an honest reading of what lycopene supplement trials have and have not shown.

Back to Table of Contents

Table of Contents

  1. Deep-Dive Articles
  2. What Is Actually in a Grapefruit
  3. Research Papers: The Drug Interaction
  4. Research Papers: Flavanones and Metabolic Health
  5. Research Papers: Vitamin C and Immunity
  6. Research Papers: Lycopene, Pectin and the Heart
  7. Research Papers: Weight and the Grapefruit Diet
  8. External Authoritative Resources
  9. Connections
  10. Featured Videos

What Is Actually in a Grapefruit

Half a medium grapefruit is around fifty calories and more than ninety percent water. That combination — large, filling, cheap, low in calories, eaten raw with a spoon — is most of why it earned its place at breakfast. But the interesting content is what comes along with the water, and it falls into five groups that the deep-dive pages take one at a time.

  1. Furanocoumarins — bergamottin and 6',7'-dihydroxybergamottin. These are the compounds behind the drug interaction, and they are the reason grapefruit is different from every other fruit in the shop. They are chemical defences the plant makes against fungi and insects, and their effect on human drug metabolism is entirely incidental. Sweet oranges, lemons, limes and mandarins do not carry meaningful amounts; pomelo, Seville orange and tangelo do.
  2. Flavanones — principally naringin, which gives grapefruit its bitterness, and naringenin, the smaller molecule your gut bacteria convert it into. Naringin is concentrated in the pith and segment membranes rather than the juice, which is why the same fruit tastes so different depending on how you eat it. These compounds carry the largest share of grapefruit's metabolic research literature.
  3. Vitamin C — roughly 35 to 45 milligrams in half a medium fruit, which is about half a day's requirement for an adult woman and a little under half for a man. Grapefruit is not the richest source available, but it is one of the most practical: raw, in season all winter, and eaten in a large enough serving to matter.
  4. Carotenoids — lycopene and beta-carotene, present only in the pink and red varieties and essentially absent from the whites. The colour is a reliable guide: the deeper the red, the more lycopene. Both are fat-soluble, which means what you eat alongside the fruit changes how much you absorb.
  5. Pectin and potassium — the least glamorous entries and arguably the best evidenced. Pectin is the soluble fibre that traps bile acids and lowers cholesterol, and it lives in the flesh and membranes, which means juicing discards it. Potassium supports blood-pressure control through a well-established mechanism.

One theme runs through all five and is worth stating once here rather than five times: the whole fruit is a better proposition than any component of it. Juice keeps the vitamin C and the lycopene but loses the pectin and much of the flavanone. A flavonoid capsule has none of the fibre, water or bulk. A lycopene supplement has none of the trial evidence the food has. Buy the fruit, eat it with a spoon, and preferably with something fatty in the same meal.

Back to Table of Contents

Research Papers: The Drug Interaction

  1. Bailey DG, Spence JD, Munoz C, Arnold JMO. Interaction of citrus juices with felodipine and nifedipine. The Lancet. 1991;337(8736):268–269. — doi:10.1016/0140-6736(91)90872-M — the accidental discovery.
  2. Bailey DG, Dresser G, Arnold JMO. Grapefruit–medication interactions: forbidden fruit or avoidable consequences? Canadian Medical Association Journal. 2013;185(4):309–316. — doi:10.1503/cmaj.120951 — the standard reference for clinicians and patients alike.
  3. Paine MF, Widmer WW, Hart HL, Pusek SN, et al. A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice–felodipine interaction. The American Journal of Clinical Nutrition. 2006;83(5):1097–1105. — doi:10.1093/ajcn/83.5.1097 — the experiment that identified the responsible compounds by removing them.
  4. Lown KS, Bailey DG, Fontana RJ, Janardan SK, et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. Journal of Clinical Investigation. 1997;99(10):2545–2553. — doi:10.1172/JCI119439 — intestinal biopsies showing the enzyme itself disappears.
  5. He K, Iyer KR, Hayes RN, Sinz MW, Woolf TF, Hollenberg PF. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chemical Research in Toxicology. 1998;11(4):252–259. — doi:10.1021/tx970192k — why the effect is irreversible rather than temporary.
  6. Lilja JJ, Kivistö KT, Neuvonen PJ. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin. Clinical Pharmacology & Therapeutics. 2000;68(4):384–390. — doi:10.1067/mcp.2000.110216 — the study behind "timing does not help".
  7. Fukazawa I, Uchida N, Uchida E, Yasuhara H. Effects of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese. British Journal of Clinical Pharmacology. 2004;57(4):448–455. — doi:10.1046/j.1365-2125.2003.02030.x — why the choice of statin matters.
  8. Seden K, Dickinson L, Khoo S, Back D. Grapefruit–drug interactions. Drugs. 2010;70(18):2373–2407. — doi:10.2165/11585250-000000000-00000
  9. Dresser GK, Bailey DG, Leake BF, Schwarz UI, et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clinical Pharmacology & Therapeutics. 2002;71(1):11–20. — doi:10.1067/mcp.2002.121152 — the interaction that runs the other way.
  10. Pirmohamed M. Drug–grapefruit juice interactions. BMJ. 2013;346:f1. — doi:10.1136/bmj.f1 — a short editorial on how much to worry.

Back to Table of Contents

Research Papers: Flavanones and Metabolic Health

  1. Alam MA, Subhan N, Rahman MM, Uddin SJ, et al. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Advances in Nutrition. 2014;5(4):404–417. — doi:10.3945/an.113.005603
  2. Bharti S, Rani N, Krishnamurthy B, Arya DS. Preclinical evidence for the pharmacological actions of naringin: a review. Planta Medica. 2014;80(6):437–451. — doi:10.1055/s-0034-1368351 — note "preclinical" in the title; the label is accurate.
  3. Mulvihill EE, Assini JM, Sutherland BG, DiMattia AS, et al. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2010;30(4):742–748. — doi:10.1161/ATVBAHA.109.201095
  4. Jung UJ, Lee MK, Jeong KS, Choi MS. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. The Journal of Nutrition. 2004;134(10):2499–2503. — doi:10.1093/jn/134.10.2499
  5. Rebello CJ, Greenway FL, Lau FH, Lin Y, et al. Naringenin promotes thermogenic gene expression in human white adipose tissue. Obesity. 2019;27(1):103–111. — doi:10.1002/oby.22352 — human tissue, studied outside the body.
  6. Rebello CJ, Beyl RA, Lertora JJL, Greenway FL, et al. Safety and pharmacokinetics of naringenin: a randomized, controlled, single-ascending-dose clinical trial. Diabetes, Obesity and Metabolism. 2020;22(1):91–98. — doi:10.1111/dom.13868 — a safety and dose study, not an efficacy trial.
  7. Salehi B, Fokou PVT, Sharifi-Rad M, Zucca P, et al. The therapeutic potential of naringenin: a review of clinical trials. Pharmaceuticals. 2019;12(1):11. — doi:10.3390/ph12010011
  8. Bailey DG, Dresser GK, Leake BF, Kim RB. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clinical Pharmacology & Therapeutics. 2007;81(4):495–502. — doi:10.1038/sj.clpt.6100104
  9. Vanamala J, Reddivari L, Yoo KS, Pike LM, Patil BS. Variation in the content of bioactive flavonoids in different brands of orange and grapefruit juices. Journal of Food Composition and Analysis. 2006;19(2–3):157–166. — doi:10.1016/j.jfca.2005.06.002
  10. Chaudhary P, Bang H, Jayaprakasha GK, Patil BS. Variation in key flavonoid biosynthetic enzymes and phytochemicals in 'Rio Red' grapefruit. Journal of Agricultural and Food Chemistry. 2016;64(47):9022–9032. — doi:10.1021/acs.jafc.6b02975

Back to Table of Contents

Research Papers: Vitamin C and Immunity

  1. Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9(11):1211. — doi:10.3390/nu9111211 — the standard modern review.
  2. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews. 2013;(1):CD000980. — doi:10.1002/14651858.CD000980.pub4 — the honest answer to the question everyone asks.
  3. Levine M, Conry-Cantilena C, Wang Y, Welch RW, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences. 1996;93(8):3704–3709. — doi:10.1073/pnas.93.8.3704
  4. Lykkesfeldt J, Tveden-Nyborg P. The pharmacokinetics of vitamin C. Nutrients. 2019;11(10):2412. — doi:10.3390/nu11102412 — why very large doses do not produce proportionally large effects.
  5. Padayatty SJ, Levine M. Vitamin C: the known and the unknown and Goldilocks. Oral Diseases. 2016;22(6):463–493. — doi:10.1111/odi.12446
  6. Carr AC, Rowe S. Factors affecting vitamin C status and prevalence of deficiency: a global health perspective. Nutrients. 2020;12(7):1963. — doi:10.3390/nu12071963 — low vitamin C is commoner than expected.
  7. Pullar JM, Carr AC, Vissers MCM. The roles of vitamin C in skin health. Nutrients. 2017;9(8):866. — doi:10.3390/nu9080866
  8. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proceedings of the National Academy of Sciences. 1989;86(16):6377–6381. — doi:10.1073/pnas.86.16.6377
  9. Cook JD, Reddy MB. Effect of ascorbic acid intake on nonheme-iron absorption from a complete diet. The American Journal of Clinical Nutrition. 2001;73(1):93–98. — doi:10.1093/ajcn/73.1.93 — the honest correction to the single-meal iron studies.
  10. Hemilä H. Vitamin C and infections. Nutrients. 2017;9(4):339. — doi:10.3390/nu9040339

Back to Table of Contents

Research Papers: Lycopene, Pectin and the Heart

  1. Habauzit V, Verny MA, Milenkovic D, Barber-Chamoux N, et al. Flavanones protect from arterial stiffness in postmenopausal women consuming grapefruit juice for 6 mo: a randomized, controlled, crossover trial. The American Journal of Clinical Nutrition. 2015;102(1):66–74. — doi:10.3945/ajcn.114.104646 — the strongest human grapefruit trial to date.
  2. Cerda JJ, Robbins FL, Burgin CW, Baumgartner TG, et al. The effects of grapefruit pectin on patients at risk for coronary heart disease without altering diet or lifestyle. Clinical Cardiology. 1988;11(9):589–594. — doi:10.1002/clc.4960110902 — the fibre component, tested on its own.
  3. Gorinstein S, Caspi A, Libman I, Lerner HT, et al. Red grapefruit positively influences serum triglyceride level in patients suffering from coronary atherosclerosis. Journal of Agricultural and Food Chemistry. 2006;54(5):1887–1892. — doi:10.1021/jf058171g — red versus blond, head to head.
  4. Cheng HM, Koutsidis G, Lodge JK, Ashor A, Siervo M, Lara J. Tomato and lycopene supplementation and cardiovascular risk factors: a systematic review and meta-analysis. Atherosclerosis. 2017;257:100–108. — doi:10.1016/j.atherosclerosis.2017.01.009
  5. Costa-Rodrigues J, Pinho O, Monteiro PRR. Can lycopene be considered an effective protection against cardiovascular disease? Food Chemistry. 2018;245:1148–1153. — doi:10.1016/j.foodchem.2017.11.055
  6. Sesso HD, Buring JE, Norkus EP, Gaziano JM. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. The American Journal of Clinical Nutrition. 2004;79(1):47–53. — doi:10.1093/ajcn/79.1.47 — observational, not causal.
  7. Story EN, Kopec RE, Schwartz SJ, Harris GK. An update on the health effects of tomato lycopene. Annual Review of Food Science and Technology. 2010;1:189–210. — doi:10.1146/annurev.food.102308.124120
  8. Unlu NZ, Bohn T, Clinton SK, Schwartz SJ. Carotenoid absorption from salad and salsa by humans is enhanced by the addition of avocado or avocado oil. The Journal of Nutrition. 2005;135(3):431–436. — doi:10.1093/jn/135.3.431 — eat it with fat.
  9. Ilic D, Forbes KM, Hassed C. Lycopene for the prevention of prostate cancer. Cochrane Database of Systematic Reviews. 2011;(11):CD008007. — doi:10.1002/14651858.CD008007.pub2 — the randomised evidence was found insufficient.
  10. Cruse RR, Lime BJ, Hensz RA. Pigmentation and color comparison of Ruby Red and Star Ruby grapefruit juice. Journal of Agricultural and Food Chemistry. 1979;27(3):641–642. — doi:10.1021/jf60223a029

Back to Table of Contents

Research Papers: Weight and the Grapefruit Diet

  1. Fujioka K, Greenway F, Sheard J, Ying Y. The effects of grapefruit on weight and insulin resistance: relationship to the metabolic syndrome. Journal of Medicinal Food. 2006;9(1):49–54. — doi:10.1089/jmf.2006.9.49 — the trial most often cited; the effect is real and small.
  2. Silver HJ, Dietrich MS, Niswender KD. Effects of grapefruit, grapefruit juice and water preloads on energy balance, weight loss, body composition, and cardiometabolic risk in free-living obese adults. Nutrition & Metabolism. 2011;8(1):8. — doi:10.1186/1743-7075-8-8 — grapefruit compared against plain water, and no better than it.
  3. Dow CA, Going SB, Chow HS, Patil BS, et al. The effects of daily consumption of grapefruit on body weight, lipids, and blood pressure in healthy, overweight adults. Metabolism. 2012;61(7):1026–1035. — doi:10.1016/j.metabol.2011.12.004 — no weight change; better lipids and blood pressure.
  4. Murphy MM, Barraj LM, Rampersaud GC. Consumption of grapefruit is associated with higher nutrient intakes and diet quality among adults, and more favorable anthropometrics in women, NHANES 2003–2008. Food & Nutrition Research. 2014;58:22179. — doi:10.3402/fnr.v58.22179 — a survey association, not a trial.
  5. Habauzit V, Morand C. Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians. Therapeutic Advances in Chronic Disease. 2012;3(2):87–106. — doi:10.1177/2040622311430006
  6. Vinson JA, Su X, Zubik L, Bose P. Phenol antioxidant quantity and quality in foods: fruits. Journal of Agricultural and Food Chemistry. 2001;49(11):5315–5321. — doi:10.1021/jf0009293
  7. Floegel A, Kim DO, Chung SJ, Koo SI, Chun OK. Comparison of ABTS/DPPH assays to measure antioxidant capacity in popular antioxidant-rich US foods. Journal of Food Composition and Analysis. 2011;24(7):1043–1048. — doi:10.1016/j.jfca.2011.01.008
  8. Dorado C, Cameron RG, Manthey JA. Analysis and potential value of compounds extracted from Star Ruby, Rio Red and Ruby Red grapefruit. Frontiers in Nutrition. 2021;8:691663. — doi:10.3389/fnut.2021.691663

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents